ProMIS Neurosciences Inc. (PMN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $29.60M
Last updated: Nov 17, 2026 at 4:23 PM ET
ProMIS Neurosciences Inc. (PMN) Statistics
ProMIS Neurosciences (PMN) has a market cap of $29.60M. Its share count is up 368.08% from a year earlier. It holds $44.07M more cash than debt, 148.90% of its market cap.
Total Valuation
| Market Cap | $29.60M |
|---|---|
| Latest price (Nov 17, 2026) | $3.21 |
Key Dates
The next earnings report is expected on Mar 23, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 23, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 67.04% over 52 weeks and trades 63.52% below its 50-day average.
| Beta (1Y) | 1.99 |
|---|---|
| 52-Week Change | -67.04% |
| 1-Month Change | -61.00% |
| 3-Month Change | -78.10% |
| 6-Month Change | -69.86% |
| 5-Year Change | -99.98% |
| 10-Year Change | -99.96% |
| Total Return (1Y) | -67.04% |
| Total Return (3Y CAGR) | -54.35% |
| Total Return (5Y CAGR) | -55.83% |
| Return vs SPY (1Y) | -76.20% |
| Max Drawdown (1Y) | -87.90% |
| Max Drawdown (3Y) | -95.73% |
| Sharpe Ratio (1Y) | -0.67 |
| Correlation with SPY (1Y) | 0.17 |
| 50-Day Average | $8.80 |
| 200-Day Average | $12.49 |
| 52-Week Range | $2.78 to $27.40 |
| RSI (14 Days) | 30.2 |
| Average Volume (20 Days) | 427.58K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 8.83x current liabilities, and total debt is 0.00x shareholder equity.
| Current Ratio | 8.83x |
|---|---|
| Quick Ratio | 8.83x |
| Debt / Equity | 0.00x |
| Interest Coverage | 37.20x |
Returns and Efficiency
Return on equity is -92.93% and return on assets is -82.29% over the last 12 months.
| Return on Equity (ROE) | -92.93% |
|---|---|
| Return on Assets (ROA) | -82.29% |
| Return on Capital Employed (ROCE) | -92.82% |
Scores
PMN has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Operating Income | -$40.30M |
| Pretax Income | -$38.82M |
| Net Income | -$38.81M |
| EBITDA | -$38.82M |
| EBIT | -$38.82M |
| Reported EPS (TTM) | -$33.48 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 88.55% of the $47.16M in total assets.
| Cash and Equivalents | $44.07M |
|---|---|
| Total Debt | $0 |
| Net Cash | $44.07M |
| Net Cash Per Share | $4.82 |
| Working Capital | $41.82M |
| Shareholder Equity | $41.76M |
| Book Value Per Share | $4.57 |
| Total Assets | $47.16M |
| Total Liabilities | $5.40M |
Balance sheet as of Sep 30, 2026.
Cash Flow
| Operating Cash Flow | -$41.43M |
|---|---|
| FCF Per Share | -$4.62 |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
PMN does not pay a dividend.
| Buyback Yield | -238.85% |
|---|---|
| Shareholder Yield | -238.85% |
Stock Splits
The last split was a 1-for-25 reverse split on Nov 28, 2025.
| Last Split Date | Nov 28, 2025 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:25 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About PMN
What is PMN's market cap?
ProMIS Neurosciences has a market cap of $29.60M.
How many shares of PMN are outstanding?
ProMIS Neurosciences has 9.14M shares outstanding. The count is up 368.08% from a year earlier.
Does PMN pay a dividend?
No. ProMIS Neurosciences does not pay a dividend.
How much debt does PMN have?
ProMIS Neurosciences has $0 of total debt and $44.07M of cash and equivalents, a net cash position of $44.07M.
PMN pages: Overview, Charting, Earnings, Forecast, Statistics, Competitors